fda glp-1 warning september 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP -1 is FDA-approved, warns FDA – Partnership for Safe Medicines

Thinking about buying GLP-1 and other products labeled “for research purposes” or “not for human consumption”? Think again. These products have not been reviewed by FDA for safety, effectiveness or

26.00

★★★★☆4.8 (126)

Thinking about buying GLP-1 and other products labeled “for research purposes” or “not for human consumption”? Think again. These products have not been reviewed by FDA for safety, effectiveness or quality and

23.79

★★★★★4.9 (98)

Why the FDA Issued 30 Warning Letters to Telehealth Sites Marketing Compounded GLP-1s

24.06

★★★★★5.0 (157)

Today, we approved the first generic for an injectable GLP-1 used to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct

23.34

★★★★★4.7 (84)

Prescription Drug Freight Fraud Report, September 2025 – Partnership for Safe Medicines

28.84

★★★★★4.9 (203)

Ozempic Lawsuits: Possible Compensation For Damages

20.97

★★★★★5.0 (176)

In patients with #obesity, incretin-based therapies such as GLP-1 receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular

23.79

★★★★★4.8 (132)